Classification of von Willebrand disease

Von Willebrand Disease: Basic and Clinical Aspects

Volumn , Issue , 2011, Pages 74-85

  Batlle, Javier ^a,b   Pérez Rodríguez, Almudena ^a   López Fernández, María Fernanda ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Bleeding score; Classification; Desmopressin; Mutations; Von Willebrand disease; Von Willebrand factor; VWF multimers

Indexed keywords

EID: 84885565579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444329926.ch6     Document Type: Chapter

References (48)

1. Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's disease, with observations on combined deficiencies of antihemophilic factor and proac-celerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 1971 ; 50: 244-54 .
2. Holmberg L, Nilsson IM. Genetic variants of von Willebrand's disease. Br Med J 1972 ; 3: 317-20 .
3. Kernoff PB, Gruson R, Rizza CR. A variant of factor 8 related antigen. Br J Haematol 1974 ; 26: 435-40 .
4. Peake IR, Bloom AL, Giddings JC. Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med 1974 ; 291: 113-17 .
5. Meyer D, Obert B, Pietu G, et al. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease. J Lab Clin Med 1980 ; 95: 590-602 .
6. Zimmerman TS, Ruggeri ZM. Von Willebrand's disease. Prog Hemost Thromb 1982 ; 6: 203-36 .
7. Ruggeri ZM, Pareti FI, Mannucci PM, et al. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980 ; 302: 1047-51 .
8. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980 ; 65: 1318-25 .
9. Holmberg L, Nilsson IM, Borge L, et al. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med 1983 ; 309: 816-21 .
10. Ruggeri ZM, Nilsson IM, Lombardi R, et al. Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest 1982 ; 70: 1124-7 .
11. Batlle J, Lopez Fernandez MF, Lasierra J, et al. von Willebrand disease type IIC with different abnormalities of von Willebrand factor in the same sibship. Am J Hematol 1986 ; 21: 177-88 .
12. Kinoshita S, Harrison J, Lazerson J, at al. A new variant of dominant type II von Willebrand's disease with aberrant multimeric pattern of factor VIII-related antigen (type IID). Blood 1984 ; 63: 1369-71 .
13. Zimmerman TS, Dent JA, Ruggeri ZM, et al. Subunit composition of plasma von Willebrand factor. Cleav age is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligom ers (types IIC, IID, and IIE). J Clin Invest 1986 ; 77: 947-51 .
14. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987 ; 70: 895-904 .
15. Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993 ; 69: 177-84 .
16. Sadler JE. A revised classification of von Willebrand disease. 1994 ; Thromb Haemost 71: 520-5 .
17. Weiss HJ, Meyer D, Rabinowitz R, et al. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high -molecular-weight multimers. N Engl J Med 1982 ; 306: 326-33 .
18. Miller JL, Castella A. Willebrand's disease: characterization of a new bleeding disorder. Blood 1982 ; 60: 790-4 .
19. Nishino M, Girma JP, Rothschild C, et al. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989 ; 74: 1591-9 .
20. Mazurier C, Dieval J, Jorieux S, et al. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and mul-timeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 1990 ; 75: 20-6 .
21. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 ; 4: 2103-14 .
22. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 ; 14: 171-232 .
23. Budde U, Schneppenheim R, Eikenboom J, et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 2008 ; 6: 762-71 .
24. Goodeve A, Eikenboom J, Castaman G, et al. Pheno-type and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007 ; 109: 112-21 .
25. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007 ; 109: 145-54 .
26. James PD, Notley C, Hegadorn C, et al. Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study. J Thromb Haemost 2007 ; 5: 1914-22 .
27. Eikenboom JCJ, Matsushita T, Reitsma PH, et al. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996 ; 88: 2433-41 .
28. Pérez -24 Rodríguez A, Garcí a-Rivero A, Lourés E, et al. Autosomal dominant C1149R von Willebrand disease (VWD): phenotypic findings and their implications. Haematologica 2009 ; 94: 679-86 .
29. Schneppenheim R, Budde U. Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update. Semin Hematol 2005 ; 42: 15-28 .
30. Sadler J, Blinder M. Von Willebrand disease: Diagnosis, classification and treatment. In: Colman R, Marder V, Claves A, George J, Goldhaber S (eds.). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 5th edn, pp 905-922. Lippincott Williams & Wilkins: Philadelphia, 2006 .
31. Meyer D , Fressinaud E , Hilbert L , et al. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Pract Res Clin Haematol 2001 ; 14: 349 - 64 .
32. Ribba AS, Loisel I, Lavergne JM, et al. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001 ; 86: 848-54 .
33. Mazurier C, Goudemand J, Hilbert L, et al. Type 2N von Willebrand disease: clinical manifestations, patho-3physiology, laboratory diagnosis and molecular biology. Best Pract Res Clin Haematol 2001 ; 14: 337-47 .
34. Lopez-Fernandez MF, Blanco-Lopez MJ, Castiñeira MP, et al. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 1992 ; 40: 20-7
35. Eikenboom JC. Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol 2001 ; 14: 365-79 .
36. Eikenboom JC, Reitsma PH, Peerlinck KM, et al. Recessive inheritance of von Willebrand's disease type I. Lancet 1993 ; 341: 982-6 .
37. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003 ; 101: 2089-93 .
38. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multi-2center study. J Thromb Haemost 2005 ; 3: 2619-26 .
39. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM -26 1 VWD). J Thromb Haemost 2006 ; 4: 766-73 .
40. Federici AB, Mazurier C, Berntorp E, et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multi-7center European study. Blood 2004 ; 103: 2032-8 .
41. Mannucci PM. Treatment of von Willebrand's Disease. N Engl J Med 2004 ; 351: 683-94 .
42. Michiels JJ, van de Velde A, van Vliet HH, et al. Response of von Willebrand factor parameters to desmo-203pressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Semin Thromb Hemost 2002 ; 28: 111-32 .
43. Castaman G, Lethagen S, Federici AB, et al. Response to desmopressin is influenced by the genotype and phe-notype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008 ; 111: 3531-9 .
44. Caron C, Hilbert L, Vanhoorelbeke K, et al. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immu-nosorbent assay based method: performances in patients with type 2B von Willebrand disease. Br J Haematol 2006 ; 133: 655 .
45. Federici AB, Canciani MT, Forza I, et al. A sensitive ristocetin cofactor activity assay with recombinant glyc-oprotein Ib α for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004 ; 89: 77-85 .
46. James P, Lillicrap D. The role of molecular genetics in diagnosing von Willebrand disease. Semin Thromb Hemost 2008 ; 34: 502-8 .
47. Batlle J, Pérez-Rodríguez A, Franqueira MD, et al. Type 2M von Willebrand disease: a variant of type 2A?. J Thromb Haemost 2008 ; 6: 388-90 .
48. Penas N, Pérez-Rodríguez A, Torea JH, et al. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia). Am J Hematol 2005 ; 80: 188-96 .